Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects
Back

A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects

Stopped

Open to: ALL

Age: 18.0 - N/A

Harrow

Medical Conditions

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The purpose of this study is to evaluate the safety and tolerability of single and multiple ascending oral doses of ASP7657 in healthy subjects.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Apr 2014 Mar 2015

INTERVENTIONAL

Intervention Type : DRUG
Intervention Description : oral

Intervention Arm Group : Part 1: ASP7657 Single Ascending Dose;Part 1: ASP7657 Single Ascending Dose - Food Effect;Part 2: ASP7657 Multiple Ascending Dose;Part 2: ASP7657 Multiple Ascending Dose Elderly;

Intervention Type : DRUG
Intervention Description : oral

Intervention Arm Group : Part 1: Placebo;Part 2: Placebo;

Intervention Type : DRUG
Intervention Description : oral

Intervention Arm Group : Part 2: Naproxen;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Parexel Early Phase Clinical Unit
    Harrow
    Middlesex
    HA1 3UJ


The study is sponsored by Astellas Pharma Europe B.V.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT02108548
Last updated 26 March 2015

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top